• Improved operational efficiencies drive strong margin growth
• Aesthetics and Whitening products continue to be the focus for new product development
• Investment in production automation and ongoing R&D to support $200m+ sales target

SDI Ltd's CEO Samantha Cheetham presented the company's FY25 performance highlights at the AGM. The key points included improved operational efficiencies continuing to drive strong margin growth, with EBITDA of $21.3m (-2.7% pcp) and revenue of $110.4m (-0.7% pcp). Gross profit margin improved by 80 bps to 62.9%. While revenue was flat, there was a mix of regional performance, with strong growth in Europe (up 5.8% in local currencies) and Brazil (up 9.7% in local currencies) offsetting weaker direct exports from Australia (down 15.3% in local currencies). The Aesthetics and Whitening product categories continued to perform well, up 4.0% and 2.0% respectively, while Amalgam sales declined by 21.9%. The company is progressing the Montrose project, with construction tenders received and planning permit secured. On the ESG front, SDI is taking steps to enhance its sustainability practices, including climate risk assessment, emissions reduction initiatives, and publishing its inaugural ESG report. Looking ahead, the company's strategy remains focused on Aesthetics and Whitening product development, achieving manufacturing and logistics efficiencies through the new Montrose site, and ongoing investment in R&D to support a $200m+ sales target.

SDI expects to achieve sales of over $200m through a combination of new product launches, manufacturing and logistics efficiencies from the new Montrose site, and ongoing investment in research and development.

SDI's strategy remains focused on driving growth in its Aesthetics and Whitening product categories, achieving operational efficiencies through the new Montrose facility, and continuing to invest in R&D to support the company's $200m+ sales target.